000 | 01918nam a2200397 a 4500 | ||
---|---|---|---|
001 | EBC3019437 | ||
003 | MiAaPQ | ||
005 | 20240121041640.0 | ||
006 | m o d | | ||
007 | cr cn||||||||| | ||
008 | 090630s2009 nyu sb 001 0 eng d | ||
010 | _z 2009027054 | ||
020 | _z9781606928431 (hardcover) | ||
020 | _a9781613243725 (electronic bk.) | ||
035 | _a(MiAaPQ)EBC3019437 | ||
035 | _a(Au-PeEL)EBL3019437 | ||
035 | _a(CaPaEBR)ebr10671002 | ||
035 | _a(OCoLC)705945748 | ||
040 |
_aMiAaPQ _cMiAaPQ _dMiAaPQ |
||
043 | _an-us--- | ||
050 | 4 |
_aRS55.2 _b.G465 2009 |
|
082 | 0 | 4 |
_a338.4/76151 _222 |
245 | 0 | 0 |
_aGeneric drugs _h[electronic resource] : _bneeds and issues / _cRyan S. Blanton, editor. |
260 |
_aNew York : _bNova Science Publishers, _c2009. |
||
300 | _a157 p. | ||
490 | 1 | _aHealth care issues, costs and access | |
504 | _aIncludes bibliographical references and index. | ||
505 | 0 | _aAuthorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, January 17, 2007 / U.S. Government Printing Office -- Safe and affordable biotech drugs : the need for a generic pathway : hearing before the Committee on Oversight and Government Reform, House of Representatives, March 26, 2007 / U.S. Government Printing Office. | |
533 | _aElectronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. | ||
650 | 0 |
_aGeneric drugs _zUnited States. |
|
655 | 4 | _aElectronic books. | |
700 | 1 | _aBlanton, Ryan S. | |
710 | 2 | _aProQuest (Firm) | |
830 | 0 | _aHealth care issues, costs, and access. | |
856 | 4 | 0 |
_uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3019437 _zClick to View |
999 |
_c152737 _d152737 |